Brophy NA - Search Results

1

Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendations.

Beck WT, Grogan TM, Willman CL, Cordon-Cardo C, Parham DM, Kuttesch JF, Andreeff M, Bates SE, Berard CW, Boyett JM, Brophy NA, Broxterman HJ, Chan HS, Dalton WS, Dietel M, Fojo AT, Gascoyne RD, Head D, Houghton PJ, Srivastava DK, Lehnert M, Leith CP, Paietta E, Pavelic ZP, Weinstein R. Beck WT, et al. Among authors: brophy na. Cancer Res. 1996 Jul 1;56(13):3010-20. Cancer Res. 1996. PMID: 8674056 Review.

2

Clinical reversal of multidrug resistance.

Sikic BI, Fisher GA, Lum BL, Brophy NA, Yahanda AM, Adler KM, Halsey J. Sikic BI, et al. Among authors: brophy na. Cancer Treat Res. 1994;73:149-65. doi: 10.1007/978-1-4615-2632-2_8. Cancer Treat Res. 1994. PMID: 7710904 Review. No abstract available.

3

Clinical trials of modulation of multidrug resistance. Pharmacokinetic and pharmacodynamic considerations.

Lum BL, Fisher GA, Brophy NA, Yahanda AM, Adler KM, Kaubisch S, Halsey J, Sikic BI. Lum BL, et al. Among authors: brophy na. Cancer. 1993 Dec 1;72(11 Suppl):3502-14. doi: 10.1002/1097-0142(19931201)72:11+<3502::aid-cncr2820721618>3.0.co;2-n. Cancer. 1993. PMID: 7902206 Review.

4

Expression of multidrug resistance gene mdr1 mRNA in a subset of normal bone marrow cells.

Marie JP, Brophy NA, Ehsan MN, Aihara Y, Mohamed NA, Cornbleet J, Chao NJ, Sikic BI. Marie JP, et al. Among authors: brophy na. Br J Haematol. 1992 Jun;81(2):145-52. doi: 10.1111/j.1365-2141.1992.tb08199.x. Br J Haematol. 1992. PMID: 1353683

5

Mdr1 gene expression in childhood acute lymphoblastic leukemias and lymphomas: a critical evaluation by four techniques.

Brophy NA, Marie JP, Rojas VA, Warnke RA, McFall PJ, Smith SD, Sikic BI. Brophy NA, et al. Leukemia. 1994 Feb;8(2):327-35. Leukemia. 1994. PMID: 7905944

6

Therapy of patients with malignant melanoma using a monoclonal antimelanoma antibody-ricin A chain immunotoxin.

Spitler LE, del Rio M, Khentigan A, Wedel NI, Brophy NA, Miller LL, Harkonen WS, Rosendorf LL, Lee HM, Mischak RP, et al. Spitler LE, et al. Among authors: brophy na. Cancer Res. 1987 Mar 15;47(6):1717-23. Cancer Res. 1987. PMID: 3493066

7

Phase II study of thalidomide in patients with unresectable hepatocellular carcinoma.

Lin AY, Brophy N, Fisher GA, So S, Biggs C, Yock TI, Levitt L. Lin AY, et al. Cancer. 2005 Jan 1;103(1):119-25. doi: 10.1002/cncr.20732. Cancer. 2005. PMID: 15565573 Free article. Clinical Trial.

8

Mitoxantrone, etoposide, and cyclosporine therapy in pediatric patients with recurrent or refractory acute myeloid leukemia.

Dahl GV, Lacayo NJ, Brophy N, Dunussi-Joannopoulos K, Weinstein HJ, Chang M, Sikic BI, Arceci RJ. Dahl GV, et al. J Clin Oncol. 2000 May;18(9):1867-75. doi: 10.1200/JCO.2000.18.9.1867. J Clin Oncol. 2000. PMID: 10784627 Clinical Trial.

9

Phase I trial of etoposide with cyclosporine as a modulator of multidrug resistance.

Yahanda AM, Alder KM, Fisher GA, Brophy NA, Halsey J, Hardy RI, Gosland MP, Lum BL, Sikic BI. Yahanda AM, et al. Among authors: brophy na. J Clin Oncol. 1992 Oct;10(10):1624-34. doi: 10.1200/JCO.1992.10.10.1624. J Clin Oncol. 1992. PMID: 1403040 Clinical Trial.

10

Alteration of etoposide pharmacokinetics and pharmacodynamics by cyclosporine in a phase I trial to modulate multidrug resistance.

Lum BL, Kaubisch S, Yahanda AM, Adler KM, Jew L, Ehsan MN, Brophy NA, Halsey J, Gosland MP, Sikic BI. Lum BL, et al. Among authors: brophy na. J Clin Oncol. 1992 Oct;10(10):1635-42. doi: 10.1200/JCO.1992.10.10.1635. J Clin Oncol. 1992. PMID: 1403041 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12 results

Search Page

Filters